The Comparative Study of Nanoparticle Carriers for Targeted Drug Delivery

Authors

  • Rhea Thurumella Gifted Gabber
  • Dr.Kristina Lilova Arizona State University
  • Virgal Torremoch University of Southeastern Philippines
  • Jothsna Kethar Gifted Gabber

DOI:

https://doi.org/10.47611/jsrhs.v13i3.7170

Keywords:

Liposomes, dendrimers, Polymeric Nanoparticles, Cancer

Abstract

 

This study compares and contrasts different types of nanoparticle carriers, such as liposomes, dendrimers, and polymeric nanoparticles. Its primary focus is on how well, specifically, and biocompatible, these nanoparticles work in focused drug delivery systems. This study uses advanced testing methods to determine how precisely these nanoparticles can target and reach specific cells or tissues. This could lead to better treatment results and fewer side effects. The research discovered that these particles carry medicine in different ways and that their size and the way their surfaces are made are significant to how well they work. Also, tests that check nanoparticles' biocompatibility show that their chemical and physical features are significant in how they interact with living things. This study helps us understand how nanoparticle medicine delivers drugs mechanically and lays the groundwork for making nanotherapeutics that work better and are safer. The results show that nanoparticle transporters could be used in specific treatments. This would lead to more personalized and precise medical care.  

 

Downloads

Download data is not yet available.

Author Biography

Dr.Kristina Lilova, Arizona State University

Research Assistant Professor at Arizona State University

References or Bibliography

Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., ... & Barnholtz-Sloan, J. S. (2020). CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017. Neuro-Oncology, 22(12), iv1-iv96.

Gutkin, A., Cohen, Z. R., & Peer, D. (2016). Harnessing nanomedicine for therapeutic intervention in glioblastoma. Expert Opinion on Drug Delivery, 13(11), 1573-1582. https://doi.org/10.1080/17425247.2016.1200557

Kim, S. S., Harford, J. B., Pirollo, K. F., & Chang, E. H. (2015). Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors, including cancer stem cells: The promise of nanomedicine. Biochemical and Biophysical Research Communications, 468(3), 485-489. https://doi.org/10.1016/j.bbrc.2015.06.137

Explore more about Nanotechnology - NIBIB

Explore More Research | National Institute of Biomedical Imaging and Bioengineering (nih.gov)

Pourgholi, F., Hajivalili, M., Farhad, J. N., Kafil, H. S., & Yousefi, M. (2016). Nanoparticles: Novel vehicles in treatment of Glioblastoma. Biomedicine & Pharmacotherapy, 77, 98-107. https://doi.org/10.1016/j.biopha.2015.12.014

National Health Expenditure Projections 2019-2028" by Centers for Medicare & Medicaid Services (CMS)

Forecast Summary 2019-2028 FINAL_0.pdf (cms.gov)

Jena, L., McErlean, E., & McCarthy, H. (2020). Delivery across the blood-brain barrier: Nanomedicine for glioblastoma multiforme. Drug Delivery and Translational Research, 10(2), 304-318. https://doi.org/10.1007/s13346-019-00679-2

Therapeutic Potential of Targeted Nanoparticles and Perspective on Nanotherapies

Therapeutic Potential of Targeted Nanoparticles and Perspective on Nanotherapies | ACS Medicinal Chemistry Letters

Published

08-31-2024

How to Cite

Thurumella, R., Lilova, D., Torremoch, V., & Kethar, J. (2024). The Comparative Study of Nanoparticle Carriers for Targeted Drug Delivery . Journal of Student Research, 13(3). https://doi.org/10.47611/jsrhs.v13i3.7170

Issue

Section

HS Research Projects